These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35344806)

  • 1. The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries.
    Lichtenberg FR
    Econ Hum Biol; 2022 Aug; 46():101124. PubMed ID: 35344806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files.
    Lichtenberg FR
    Forum Health Econ Policy; 2013 Jan; 16(1):1-33. PubMed ID: 31419866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000-2009.
    Lichtenberg FR
    Econ Hum Biol; 2014 Mar; 13():107-27. PubMed ID: 23664114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999-2010.
    Lichtenberg FR; Tatar M; Çalışkan Z
    Health Policy; 2014 Sep; 117(3):361-73. PubMed ID: 24996837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical innovation and the longevity of Australians: a first look.
    Lichtenberg FR; Duflos G
    Adv Health Econ Health Serv Res; 2008; 19():95-117. PubMed ID: 19548515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pharmaceutical innovation on the longevity and hospitalization of New Zealand cancer patients, 1998-2017.
    Lichtenberg FR
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):476-477. PubMed ID: 33412958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANALYSIS OF TRENDS IN LIFE EXPECTANCIES AND PER CAPITA GROSS DOMESTIC PRODUCT AS WELL AS PHARMACEUTICAL AND NON-PHARMACEUTICAL HEALTHCARE EXPENDITURES.
    Hermanowski T; Bystrov V; Staszewska-Bystrova A; Szafraniec-Buryło SI; Rabczenko D; Kolasa K; Orlewska E
    Acta Pol Pharm; 2015; 72(5):1045-50. PubMed ID: 26665412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995-2012.
    Lichtenberg FR
    Eur J Health Econ; 2016 Sep; 17(7):833-54. PubMed ID: 26342826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000-2011.
    Lichtenberg FR
    Int J Health Econ Manag; 2015 Sep; 15(3):339-359. PubMed ID: 27878681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003.
    Lichtenberg FR
    Health Econ; 2009 May; 18(5):519-34. PubMed ID: 18634121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pharmaceutical innovation on the burden of disease in Ireland, 2000-2015.
    Lichtenberg FR
    J Public Health (Oxf); 2020 Nov; 42(4):816-827. PubMed ID: 31927585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quality of medical care, behavioral risk factors, and longevity growth.
    Lichtenberg FR
    Int J Health Care Finance Econ; 2011 Mar; 11(1):1-34. PubMed ID: 21188512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social Policy Expenditures and Life Expectancy in High-Income Countries.
    Reynolds MM; Avendano M
    Am J Prev Med; 2018 Jan; 54(1):72-79. PubMed ID: 29254555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of pharmaceutical innovation on the burden of disease in Canada, 2000-2016.
    Lichtenberg FR
    SSM Popul Health; 2019 Aug; 8():100457. PubMed ID: 31440578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000-2013.
    Lichtenberg FR
    Int Health; 2019 Sep; 11(5):403-416. PubMed ID: 30912800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence.
    Hostenkamp G; Lichtenberg FR
    Soc Sci Med; 2015 Apr; 130():162-71. PubMed ID: 25703669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of pharmaceutical innovation to longevity growth in Germany and France, 2001-7.
    Lichtenberg FR
    Pharmacoeconomics; 2012 Mar; 30(3):197-211. PubMed ID: 22283691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis.
    Lichtenberg FR
    Forum Health Econ Policy; 2019 Apr; 21(2):. PubMed ID: 31017868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adoption of pharmaceutical innovation and its impact on the treatment costs for Alzheimer's disease in Taiwan.
    Lo TF; Hsieh CR
    J Ment Health Policy Econ; 2014 Sep; 17(3):107-17. PubMed ID: 25543114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of pharmaceutical innovation on premature mortality, cancer mortality, and hospitalization in Slovenia, 1997-2010.
    Lichtenberg FR
    Appl Health Econ Health Policy; 2015 Apr; 13(2):207-22. PubMed ID: 25564200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.